Quarterly Financial Highlights Signal Strong Growth Momentum
The June 2026 quarter saw Apollo Hospitals achieve its highest-ever quarterly net sales of ₹7,043.50 crores, reflecting a significant acceleration in revenue growth compared to previous quarters. This surge is complemented by a peak PBDIT (Profit Before Depreciation, Interest and Taxes) of ₹1,092.10 crores, marking the strongest operating profit performance in the company’s recent history.
Operating profit margins have expanded notably, with the operating profit to net sales ratio reaching an all-time high of 15.51%. This margin expansion indicates improved cost management and operational leverage, which have been key drivers behind the company’s enhanced profitability.
Further emphasising the company’s financial strength, the operating profit to interest coverage ratio surged to 9.07 times, the highest recorded in the last three months. This robust coverage ratio highlights Apollo Hospitals’ strong ability to service its debt obligations comfortably, reducing financial risk and enhancing investor confidence.
Profitability Metrics Reach New Heights
Profit before tax (excluding other income) climbed to ₹750.00 crores, while net profit after tax (PAT) hit ₹580.70 crores, both representing record quarterly figures. Earnings per share (EPS) also rose to ₹40.38, the highest in recent quarters, signalling strong returns for shareholders.
Return on Capital Employed (ROCE) for the half-year period stood at an impressive 17.41%, underscoring the company’s efficient utilisation of capital to generate profits. This metric is particularly significant in the capital-intensive hospital sector, where asset efficiency is a critical determinant of long-term success.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Comparative Performance and Market Position
Apollo Hospitals’ stock price closed at ₹8,640 on 13 Aug 2026, up 0.88% from the previous close of ₹8,565. The stock has traded within a 52-week range of ₹6,680 to ₹9,326.80, reflecting healthy volatility and investor interest. The day’s trading saw a high of ₹8,784.65 and a low of ₹8,610.30, indicating strong intra-day momentum.
When compared to the broader market benchmark, the Sensex, Apollo Hospitals has outperformed significantly over multiple time horizons. Year-to-date (YTD), the stock has delivered a remarkable 22.68% return, while the Sensex has declined by 8.73%. Over the past year, Apollo Hospitals gained 10.65%, contrasting with the Sensex’s 3.43% decline. The company’s long-term performance is even more impressive, with a 10-year return of 509.95% versus the Sensex’s 176.28%.
Upgraded Mojo Grade Reflects Strong Buy Sentiment
Reflecting these robust financials and market performance, Apollo Hospitals’ Mojo Grade was upgraded from Hold to Buy on 11 May 2026, with a current Mojo Score of 77.0. This upgrade signals increased confidence in the company’s growth prospects and financial health. The company is classified as a large-cap stock within the hospital sector, further reinforcing its stature as a market leader.
Notably, there are no key negative triggers identified in the recent analysis, underscoring the stability and resilience of Apollo Hospitals’ business model amid evolving market conditions.
Sectoral Context and Industry Positioning
Operating within the hospital industry, Apollo Hospitals continues to leverage its extensive network and brand equity to capture growing healthcare demand in India. The sector has witnessed increasing patient volumes and rising healthcare expenditure, trends that Apollo has capitalised on effectively. The company’s ability to sustain margin expansion while scaling operations is a testament to its operational excellence and strategic foresight.
Curious about Apollo Hospitals Enterprise Ltd. from Hospital? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Outlook and Investor Considerations
With its very positive financial trend and record quarterly results, Apollo Hospitals is well-positioned to maintain its growth trajectory. Investors should note the company’s strong capital efficiency, as evidenced by the 17.41% ROCE, and its ability to generate healthy operating margins despite sectoral challenges.
The absence of negative triggers and the recent upgrade to a Buy rating further enhance the stock’s appeal. However, investors should remain mindful of broader macroeconomic factors and healthcare regulatory developments that could influence future performance.
Overall, Apollo Hospitals Enterprise Ltd. stands out as a compelling large-cap investment within the hospital sector, combining robust financial metrics with a proven track record of delivering shareholder value.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
